Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
International Journal of Cancer
|
December 9, 2014
Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Joanne Kotsopoulos, Jan Lubinski, Jacek Gronwald, et al.
Obesity (Silver Spring, Md.)
|
January 21, 2012
Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers
Jacob McGee, Joanne Kotsopoulos, Jan Lubinski, et al.
Cancer Causes & Control : CCC
|
August 30, 2003
Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States)
Francesmary Modugno, Roxana Moslehi, Roberta B Ness, et al.
Lab on a Chip
|
December 20, 2018
A scalable filtration method for high throughput screening based on cell deformability
Navjot Kaur Gill, Chau Ly, Kendra D Nyberg, et al.
Breast Cancer Research and Treatment
|
January 19, 2016
Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study
Joanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, et al.
Familial Cancer
|
April 4, 2015
Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study
Yakir Segev, Barry Rosen, Jan Lubinski, et al.
Gynecologic Oncology
|
May 26, 2018
Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation
Joanne Kotsopoulos, Jacek Gronwald, Beth Karlan, et al.
The Lancet. Oncology
|
January 2, 2007
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study
John R McLaughlin, Harvey A Risch, Jan Lubinski, et al.
Gynecologic Oncology
|
April 9, 2013
The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study
Yakir Segev, Javaid Iqbal, Jan Lubinski, et al.
British Journal of Cancer
|
April 12, 2019
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation
Kelly Metcalfe, Andrea Eisen, Leigha Senter, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
International Journal of Cancer
|
December 9, 2014
Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Joanne Kotsopoulos, Jan Lubinski, Jacek Gronwald, et al.
Obesity (Silver Spring, Md.)
|
January 21, 2012
Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers
Jacob McGee, Joanne Kotsopoulos, Jan Lubinski, et al.
Cancer Causes & Control : CCC
|
August 30, 2003
Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States)
Francesmary Modugno, Roxana Moslehi, Roberta B Ness, et al.
Lab on a Chip
|
December 20, 2018
A scalable filtration method for high throughput screening based on cell deformability
Navjot Kaur Gill, Chau Ly, Kendra D Nyberg, et al.
Breast Cancer Research and Treatment
|
January 19, 2016
Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study
Joanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, et al.
Familial Cancer
|
April 4, 2015
Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study
Yakir Segev, Barry Rosen, Jan Lubinski, et al.
Gynecologic Oncology
|
May 26, 2018
Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation
Joanne Kotsopoulos, Jacek Gronwald, Beth Karlan, et al.
The Lancet. Oncology
|
January 2, 2007
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study
John R McLaughlin, Harvey A Risch, Jan Lubinski, et al.
Gynecologic Oncology
|
April 9, 2013
The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study
Yakir Segev, Javaid Iqbal, Jan Lubinski, et al.
British Journal of Cancer
|
April 12, 2019
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation
Kelly Metcalfe, Andrea Eisen, Leigha Senter, et al.
Page
of 9